NET PROFIT (x1000 EUR)
St. Jude Medical Systems AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
2 |
| Earnings before taxes |
234
|
240
|
51 |
| EBITDA |
-1
|
0
|
0 |
| Total assets |
7,335
|
7,372
|
7,112 |
| Current assets |
620
|
421
|
180 |
| Current liabilities |
86
|
60
|
11 |
| Equity capital |
7,250
|
7,312
|
7,101 |
| - share capital |
17
|
18
|
18 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.8%
|
99.2%
|
99.8% |
| Turnover per employee | |||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
3.2%
|
3.3%
|
0.7% |
| Current ratio |
720.9%
|
701.7%
|
1636.4% |
| Return on equity (ROE) |
3.2%
|
3.3%
|
0.7% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.